Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Besides the q-figures the future prospects are important......

I have over simplified the issue... you are correct... I see the (336)reexam as a non issue(ALL IMHO)... this is an ex-parte with TPL/Allicense the new instruction for PTO is to use any court documentation/precedings as reference .... I think you may be right though that the market may see this as uncertainty.... But it seems like the educated investor would see this.... so we would see more buying... the bottm line you may be right... but logic tells me reexam a non issue,,

Transparancy I agree with you (read my December post right before the settelmet annoucement but we knew a settekemnt was coming)) The market would not move the stock high till we new the terms of the agreement with J2.5... well April9th we will get some additional transparancy...

GOOD LUCK S402

Share
New Message
Please login to post a reply